Cargando…
Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials
Globally, approximately 1 in 4 cancers in women are diagnosed as breast cancer (BC). Despite significant advances in the diagnosis and therapy BCs, many patients develop metastases or relapses. Hence, novel therapeutic strategies are required, that can selectively and efficiently kill malignant cell...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768851/ https://www.ncbi.nlm.nih.gov/pubmed/33488814 http://dx.doi.org/10.1177/1849543520983196 |